HOYA CORPORATION
8
14M
6
0.10
3
0.25
1
- Areas of investment
Summary
In 1941 was created HOYA CORPORATION, which is appeared as Corporate Investor. The main department of described Corporate Investor is located in the Tokyo. The venture was found in Asia in Japan.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the HOYA CORPORATION, startups are often financed by Walden International, U.S. Venture Partners (USVP), Morgenthaler Ventures. The meaningful sponsors for the fund in investment in the same round are Walden International, U.S. Venture Partners (USVP), Santen Pharmaceutical. In the next rounds fund is usually obtained by Santen Pharmaceutical, Saints Capital, EASME - EU Executive Agency for SMEs.
The fund has no specific favorite in a number of founders of portfolio startups. Among the various public portfolio startups of the fund, we may underline InnFocus Inc, 3NT Medical, Novuson Surgical, Inc. Among the most successful fund investment fields, there are Service Industry, Optical Communication. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.
The important activity for fund was in 2018. Despite it in 2019 the fund had an activity. Opposing the other organizations, this HOYA CORPORATION works on 9 percentage points less the average amount of lead investments. Considering the real fund results, this Corporate Investor is 20 percentage points more often commits exit comparing to other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year. The increased amount of exits for fund were in 2016.
Investments analytics
Analytics
- Total investments
- 8
- Lead investments
- 3
- Exits
- 1
- Rounds per year
- 0.10
- Follow on index
- 0.25
- Investments by industry
- Medical Device (7)
- Health Care (5)
- Medical (4)
- Biotechnology (4)
- Manufacturing (2) Show 5 more
- Investments by region
-
- United States (6)
- Israel (2)
- Peak activity year
- 2020
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 11
- Avg. valuation at time of investment
- 4M
- Group Appearance index
- 0.88
- Avg. company exit year
- 13
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Cryosa | 23 Sep 2021 | Biotechnology, Health Care, Medical Device, Clinical Trials | Early Stage Venture | 21M | United States, Minnesota |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.